Dr. Himabindu Reddy, MD
What this data tells you about Dr. Reddy
Dr. Himabindu Reddy is a rheumatology specialist in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 5,923 Medicare services across 2,114 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $69,457 from 38 pharmaceutical and/or device companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,102 | $18 | $34 |
| Office visit, established patient (30-39 min) | 941 | $89 | $216 |
| Comprehensive metabolic blood panel | 430 | $10 | $29 |
| Complete blood count (CBC) with differential | 426 | $8 | $22 |
| Sed rate test (inflammation marker) | 425 | $3 | $8 |
| C-reactive protein test (inflammation marker) | 425 | $5 | $15 |
| Blood draw (venipuncture) | 352 | $8 | $10 |
| Office visit, established patient (20-29 min) | 160 | $52 | $150 |
| New patient office visit (45-59 min) | 104 | $111 | $331 |
| Measurement of complement (immune system proteins), antigen, | 78 | $12 | $33 |
| Tuberculosis test, gamma interferon | 50 | $61 | $125 |
| Measurement of dna antibody, native or double stranded | 39 | $13 | $38 |
| Vitamin D level test | 37 | $29 | $75 |
| Creatinine test (kidney function) | 37 | $5 | $15 |
| Hepatitis c antibody measurement | 36 | $14 | $40 |
| Total protein level, urine | 35 | $4 | $12 |
| Urinalysis with microscopic exam | 33 | $3 | $9 |
| Drug injection, under skin or into muscle | 22 | $11 | $54 |
| Administration of chemotherapy into vein, 1 hour or less | 21 | $103 | $340 |
| Thyroid stimulating hormone (TSH) test | 20 | $16 | $48 |
| Rheumatoid factor level | 19 | $6 | $16 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $6 | $15 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $89 | $162 |
| Lipid panel (cholesterol and triglycerides) | 16 | $13 | $37 |
| Parathyroid hormone level test | 16 | $40 | $114 |
| Office visit, established patient, complex (40-54 min) | 16 | $140 | $293 |
| Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when perfor | 16 | $28 | $66 |
| Creatine kinase (cardiac enzyme) level, total | 15 | $6 | $18 |
| Measurement of antibody for rheumatoid arthritis assessment | 15 | $13 | $45 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for rheumatology in TX.
Geographic Context
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reddy is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 9% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with denosumab injection (prolia/xgeva)?
Does Dr. Reddy receive payments from pharmaceutical companies?
How do Dr. Reddy's costs compare to other rheumatologists in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology